SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
Clinical trial NCT03669614 · UNKNOWN
Trial details
- NCT number
- NCT03669614
- Sponsor
- Aridis Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-07
- Primary completion
- 2023-07-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.